[go: up one dir, main page]

BR0214694A - 1,3-diarylprop-2-en-1-ones, compositions containing them and use - Google Patents

1,3-diarylprop-2-en-1-ones, compositions containing them and use

Info

Publication number
BR0214694A
BR0214694A BR0214694-0A BR0214694A BR0214694A BR 0214694 A BR0214694 A BR 0214694A BR 0214694 A BR0214694 A BR 0214694A BR 0214694 A BR0214694 A BR 0214694A
Authority
BR
Brazil
Prior art keywords
diarylprop
ones
compositions containing
diarilprop
onas
Prior art date
Application number
BR0214694-0A
Other languages
Portuguese (pt)
Inventor
Patrick Mailliet
Cecile Combeau
Maria-Christine Bissery
Marie-Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0214694A publication Critical patent/BR0214694A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

"1,3-DIARILPROP-2-EN-1-ONAS, COMPOSIçõES QUE AS CONTêM E UTILIZAçãO". 1,3-diarilprop-2-en-1-onas e derivados, composições que os contêm, processo de fabricação e utilização. A presente invenção se refere notadamente às novs 1,3-diarilprop-2-en-1-onas substituídas com uma atividade terapêutica, utilizáveis em particular, em oncologia."1,3-DIARILPROP-2-EN-1-ONAS, COMPOSITIONS CONTAINING THEM AND USE". 1,3-Diarylprop-2-en-1-ones and derivatives, compositions containing them, process of manufacture and use. The present invention relates notably to the therapeutic activity substituted 1,3-diarylprop-2-en-1-ones, particularly usable in oncology.

BR0214694-0A 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing them and use BR0214694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (en) 2001-12-05 2001-12-05 1,3-DIARYLPROP-2-IN-1-ONES, COMPOSITIONS CONTAINING THEM, AND USE
FR0214217 2002-11-14
PCT/FR2002/004143 WO2003048106A2 (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof

Publications (1)

Publication Number Publication Date
BR0214694A true BR0214694A (en) 2004-12-14

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214694-0A BR0214694A (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing them and use

Country Status (23)

Country Link
EP (1) EP1453790A2 (en)
JP (1) JP2005531494A (en)
KR (1) KR20050044712A (en)
CN (1) CN1612856A (en)
AR (1) AR037479A1 (en)
AU (1) AU2002365644A1 (en)
BR (1) BR0214694A (en)
CA (1) CA2469193A1 (en)
CO (1) CO5580759A2 (en)
EA (1) EA006803B1 (en)
HR (1) HRP20040508A2 (en)
HU (1) HUP0500100A2 (en)
IL (1) IL162223A0 (en)
MA (1) MA27351A1 (en)
MX (1) MXPA04005226A (en)
NZ (1) NZ533224A (en)
PA (1) PA8558501A1 (en)
PE (1) PE20030758A1 (en)
PL (1) PL370676A1 (en)
RS (1) RS47804A (en)
SV (1) SV2003001422A (en)
TW (1) TW200300685A (en)
WO (1) WO2003048106A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (en) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-ARYL-3- (INDOL-5-YL) -PROP-2-EN-1-ONES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
EP1598353A1 (en) 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
KR102636496B1 (en) 2018-09-14 2024-02-15 삼성전자주식회사 Communication device and electronic device including the communication device
CN109467549B (en) * 2018-12-07 2021-02-09 中国药科大学 Quinoline-substituted chalcone compound, its preparation method and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (en) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd Propenone derivative
BR9607708A (en) * 1995-12-01 1998-01-13 Kyowa Hakko Kogyo Kk Propenone derivative
AU7908098A (en) * 1997-06-26 1999-01-19 Statens Serum Institut Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

Also Published As

Publication number Publication date
PE20030758A1 (en) 2003-10-07
CN1612856A (en) 2005-05-04
SV2003001422A (en) 2003-07-10
EA006803B1 (en) 2006-04-28
TW200300685A (en) 2003-06-16
AR037479A1 (en) 2004-11-10
MXPA04005226A (en) 2004-10-11
HRP20040508A2 (en) 2005-08-31
RS47804A (en) 2006-12-15
IL162223A0 (en) 2005-11-20
PL370676A1 (en) 2005-05-30
WO2003048106A3 (en) 2004-03-25
CO5580759A2 (en) 2005-11-30
KR20050044712A (en) 2005-05-12
CA2469193A1 (en) 2003-06-12
EP1453790A2 (en) 2004-09-08
HUP0500100A2 (en) 2005-05-30
MA27351A1 (en) 2005-06-01
NZ533224A (en) 2006-03-31
PA8558501A1 (en) 2003-09-05
WO2003048106A2 (en) 2003-06-12
JP2005531494A (en) 2005-10-20
EA200400764A1 (en) 2004-12-30
AU2002365644A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
BR0307960A (en) N-aminoacetyl pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
BRPI0412411A (en) substituted tetrahydro-1h-pyrazol [3,4-c] pyridines, compositions containing them and use
ATE469136T1 (en) INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1
BRPI0409716A (en) 2-acylamino-4-phenylthiazole derivatives, their preparation and their application in therapeutic
SE0001899D0 (en) New compounds
BRPI0411916A (en) sulfonamide-substituted imidazoquinolines
SE0102616D0 (en) Novel compounds
BR0307564A (en) Nicotinamide derivatives useful as pde4 inhibitors
NO20062644L (en) DPP-IV inhibitors
BR0309556A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
BRPI0518758A2 (en) acetamide compounds as fungicides
BRPI0510777A (en) substituted indazoles, compositions containing them, production process and use
UY29246A1 (en) NEW COMPOUNDS
TNSN08024A1 (en) 7-substituted aza-indazoles, compositions containing same, production method and use thereof
BRPI0412851A (en) n-methyl-substituted benzamidazoles
BR0308787A (en) N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
BR0007527A (en) Phenylphenanthridines with IV-dependent inhibitory activity
SE0101387D0 (en) Novel compounds
BR0206588A (en) Compound, process for producing same, use thereof, pharmaceutical composition, and method for treating a patient afflicted with a pathological condition susceptible to amelioration by alpha4beta1 and / or alpha4beta7 integrin antagonism
BR0307998A (en) Substituted hydroxyethylamines
BRPI0412130A (en) tetracyclic compounds as c-met inhibitors
BR0206501A (en) Cruzipain and other cysteine protease inhibitors
DK1789398T3 (en) 2-amino-quinazoline derivatives useful as B-secretase (BACE) inhibitors
BRPI0411001A (en) arylheteroaromatic products, compositions containing them and use
BRPI0512352A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.